First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer: Study Dr. Kamal Kant Kohli1 Oct 2025 8:15 AM ISTA new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from...
Stem cells may offer new hope for end-stage kidney disease treatment, suggests research Dr. Kamal Kant Kohli29 Sept 2025 8:30 PM ISTMore than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the...
Validated nomogram may Predict upper GI bleeding in peritoneal dialysis Patients: Study Dr Riya Dave26 Sept 2025 8:30 PM ISTResearchers have found in a new study that Calcium and PPI use, history of upper gastrointestinal bleeding (UGIB), hemoglobin levels, and uric acid...
Albuminuria, Not Kidney Function, Predicts Future Cancer Risk, reveals study Dr Riya Dave26 Sept 2025 8:45 AM ISTResearchers have determined in a new study that albuminuria, and not diminished kidney function, is independently associated with a greater risk of...
Empagliflozin exhibits Safety and Renal Effects in Cirrhosis With T2DM: Study Dr. Shravani Dali26 Sept 2025 8:30 AM ISTA new clinical study has explored the role of empagliflozin in patients living with cirrhosis and type 2 diabetes mellitus, highlighting both its...
Bout of cystitis may signal presence of urogenital cancers in middle-aged adults, suggests study Dr. Kamal Kant Kohli23 Sept 2025 9:45 PM ISTA bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers-which affect parts of the body involved in...
Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva Ruchika Sharma23 Sept 2025 11:24 AM ISTHyderabad: Dr Reddy's Laboratories Ltd., has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
New tracer could enable surgeons to see and hear prostate cancer: Study Dr. Kamal Kant Kohli19 Sept 2025 11:00 PM ISTA preclinical evaluation of a new 'dual-mode' tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but...
Lower Irisin Levels Linked to Diabetic Nephropathy Progression in T2DM: Study Dr. Shravani Dali18 Sept 2025 11:00 AM ISTA newly published study suggests that lower circulating irisin levels in patients with type 2 diabetes (T2DM) are associated with impaired renal...
Vasectomy More Cost-Effective Than Salpingectomy for Permanent Contraception, Reveals Research Medha Baranwal15 Sept 2025 10:30 PM ISTUSA: Researchers have found in a new cost-effectiveness analysis that vasectomy is a more cost-effective permanent contraceptive option. While...
FDA Approves INLEXZO for BCG-Unresponsive Bladder Cancer Dr. Kamal Kant Kohli15 Sept 2025 8:30 PM ISTThe U.S. FDA has approved Johnson & Johnson's INLEXZO (gemcitabine intravesical system) for adults with BCG-unresponsive non-muscle invasive...
Rheumatoid Arthritis Patients Face Higher Risk of Kidney Stones: Study Dr. Shravani Dali14 Sept 2025 9:00 PM ISTKidney stone disease remains a growing health concern worldwide, with metabolic, inflammatory, and lifestyle factors all contributing to risk. New...
